Surveillance urodynamics for neurogenic lower urinary tract dysfunction: A systematic review.

INTRODUCTION Baseline urodynamic characterization in patients with neurogenic lower urinary tract dysfunction (NLUTD) allows detection of unsafe storage and voiding pressures and optimization of these parameters through medical or surgical intervention. Surveillance urodynamics (sUDS) studies are performed in the ambulatory setting after baseline characterization, with the goal of monitoring bladder function. How often this study should be performed and the circumstances that should prompt repeated studies are unknown. The primary objective of this review is to evaluate the evidence supporting sUDS in the setting of NLUTD as assessed by whether the study leads to 1) change in patient management; 2) determination of new findings not suggested by imaging or symptoms; and 3) demonstration of superior outcomes compared to observation. The secondary objective is to review sUDS practice patterns among urologists in their assessment of NLUTD. METHODS PubMed, EMBASE, and Cochrane Library databases were reviewed for English-language literature published between January 1975 and March 2018. RESULTS Twenty-eight independent articles (1368 patients, 9486 patient-years of followup) were included. Given heterogeneous data, 49% of 263 subjects were asymptomatic, yet demonstrated sUDS abnormality prompting treatment. Eight cross-sectional studies (four spinal cord injury [SCI], two NLUTD, two spina bifida) surveyed urologists regarding current sUDS patterns; 53% of 498 respondents perform sUDS between one and three years. CONCLUSIONS Evidence supporting optimal surveillance for NLUTD is lacking. Level 2b-4 evidence suggests that sUDS is likely to modify patient treatment and often demonstrates findings that modify treatment in the absence of symptoms or imaging changes.

[1]  S. Shariff,et al.  The use of urologic investigations among patients with traumatic spinal cord injuries. , 2016, Research and reports in urology.

[2]  C. Saigal,et al.  Urological Surveillance and Medical Complications after Spinal Cord Injury in the United States. , 2015, Urology.

[3]  T. Kessler,et al.  Neurogenic lower urinary tract dysfunction (NLUTD) in patients with spinal cord injury: long‐term urodynamic findings , 2015, BJU international.

[4]  J. Winters,et al.  AUA/SUFU adult urodynamics guideline: a clinical review. , 2014, The Urologic clinics of North America.

[5]  J. R. Ruud Bosch,et al.  Assessment of bladder and kidney functioning in adult spina bifida patients by Dutch urologists: A survey , 2014, Neurourology and urodynamics.

[6]  T. Linsenmeyer,et al.  Impact of annual urodynamic evaluations on guiding bladder management in individuals with spinal cord injuries , 2013, The journal of spinal cord medicine.

[7]  E. Frohman,et al.  Renal deterioration in multiple sclerosis patients with neurovesical dysfunction , 2013, Multiple sclerosis.

[8]  H. Foster,et al.  Renal tract ultrasonography for routine surveillance in spinal cord injury patients. , 2013, Topics in spinal cord injury rehabilitation.

[9]  J. Pannek,et al.  EAU guidelines on neurogenic lower urinary tract dysfunction. , 2009, European urology.

[10]  B. Blok,et al.  Management of neurogenic bladder patients in the Netherlands: do urologists follow guidelines? , 2008, Neurourology and urodynamics.

[11]  J. Pannek,et al.  A PROPOSED GUIDELINE FOR THE UROLOGICAL MANAGEMENT OF PATIENTS WITH SPINAL CORD INJURY , 2008, BJU international.

[12]  J. Capolicchio,et al.  Postpubertal urodynamic and upper urinary tract changes in children with conservatively treated myelomeningocele. , 2007, The Journal of urology.

[13]  Jürgen Pannek,et al.  Clinical usefulness of urodynamic assessment for maintenance of bladder function in patients with spinal cord injury , 2007, Neurourology and urodynamics.

[14]  G. Karsenty,et al.  Urological surveillance and management of patients with neurogenic bladder: Results of a survey among practicing urologists in Canada. , 2006, The Canadian journal of urology.

[15]  T. Yamanishi,et al.  Practice patterns of Japanese physicians in urologic surveillance and management of spinal cord injury patients , 2006, Spinal Cord.

[16]  H. Bruschini,et al.  Upper and lower urinary tract evaluation of 104 patients with myelomeningocele without adequate urological management , 2006, World Journal of Urology.

[17]  P. Albertsen Variation in Urological Practice Amongst Spinal Injuries Units in the UK and Eire. , 2005, The Journal of urology.

[18]  P. Rubenwolf [Prognostic value of urodynamic testing in myelodysplastic patients]. , 2003, Aktuelle Urologie.

[19]  A. Gousse,et al.  Current practice patterns in the urologic surveillance and management of patients with spinal cord injury. , 2003, Urology.

[20]  V. Rivera,et al.  Urodynamic pattern changes in multiple sclerosis. , 2001, Urology.

[21]  S. Khoshbin,et al.  Long-term followup of newborns with myelodysplasia and normal urodynamic findings: Is followup necessary? , 1999, The Journal of urology.

[22]  E. Frohman,et al.  Multiple sclerosis and the urologist. , 1999, The Journal of urology.

[23]  J. Wyndaele Correlation between clinical neurological data and urodynamic function in spinal cord injured patients , 1997, Spinal Cord.

[24]  E. McGuire,et al.  Decreased bladder compliance in patients with myelomeningocele treated with radiological observation. , 1996, The Journal of urology.

[25]  A. Atala,et al.  The long-term urological response of neonates with myelodysplasia treated proactively with intermittent catheterization and anticholinergic therapy. , 1995, The Journal of urology.

[26]  M. Mayo,et al.  Long-term urodynamic follow up in pediatric spinal cord injury , 1994, Paraplegia.

[27]  E. Dehoux,et al.  Risk factors for upper tract deterioration in chronic spinal cord injury patients. , 1992, The Journal of urology.

[28]  B. Bemelmans,et al.  Evidence for early lower urinary tract dysfunction in clinically silent multiple sclerosis. , 1991, The Journal of urology.

[29]  S. Khoshbin,et al.  The changing neurourologic lesion in myelodysplasia. , 1987, JAMA.

[30]  I. Goldstein,et al.  The changing neurourologic pattern of multiple sclerosis. , 1983, The Journal of urology.

[31]  D. Sax,et al.  Neurourologic abnormalities in multiple sclerosis. , 1982, The Journal of urology.

[32]  H. Schoenberg,et al.  Management of vesical dysfunction in multiple sclerosis. , 1980, Urology.

[33]  J. Blaivas,et al.  Vesicourethral dysfunction in multiple sclerosis. , 1979, The Journal of urology.

[34]  Waleed Al Taweel,et al.  Neurogenic bladder evaluation and management after spinal cord injury: Current practice among urologists working in Saudi Arabia , 2011, Urology annals.

[35]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[36]  Ali Al-Ameri,et al.  National institute for Health and Clinical excellence guidance , 2007 .

[37]  S. Elliott,et al.  Bacteriuria management and urological evaluation of patients with spina bifida and neurogenic bladder: a multicenter survey. , 2005, The Journal of urology.

[38]  K. Kropp,et al.  Preservation of renal function in children with myelomeningocele managed with basic newborn evaluation and close followup. , 2003, The Journal of urology.